top of page

Closed-Loop Brain Neuromodulation

Exploring a new way of treating epilepsy

Current Challenges of
Treating Drug-Resistant Epilepsy

Drug-resistant epilepsy (DRE) is a condition in which patients do not respond to available medications and experience recurrent seizures. DRE affects a significant portion of the global population with at least 30% of epilepsy patients experiencing this condition. Unfortunately, available treatment options such as surgery or medication adjustments may not effectively manage DRE patients, and pose side effects or risks.

Although there is a promising solution for DRE known as neuromodulation, there are still several drawbacks that need to be addressed, including limited efficacy, imprecise stimulation, and non-personalized treatment.

Our  Solution

INOPASE offers a cutting-edge closed-loop stimulation technology for DRE, with a vision to improve current neuromodulation drawbacks. Our innovative solution offers several advantages, including:

​​

  1. Pre-symptomatic detection: Timely stimulation to prevent symptoms before they occur, tailored to each patient for optimal treatment.

  2. Personalized treatment: Stimulation adaptable to individual condition, ensuring that each patient receives the most effective treatment possible.

  3. Broad, high-density EEG recordings: We offer 64-128 implantable electrodes with thinner and more flexible material, to identify the precise epileptic onset zone.

  4. Precise Stimulation: By using broad and high-density electrodes, doctors can locate the optimal brain site for precise stimulation, improving treatment outcomes.    

Together, these features make our solution a highly promising and innovative approach to managing DRE, with the potential to significantly improve patients' lives.

Collaboration  of  Technologies  and  Clinical  Knowledge

YCU_Logo.png

Yokohama City University 

index-pic-index02-6.jpg.webp

Tokyo Institute of Technolog

Wireless Powered Closed Loop Neuromodulation

bottom of page